Mimedx (MDXG) Revenue Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -33.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.12% |
| Dec 31, 2025 | 27.11% |
| Sep 30, 2025 | 35.30% |
| Jun 30, 2025 | 13.07% |
| Mar 31, 2025 | 4.13% |
| Dec 31, 2024 | 7.00% |
| Sep 30, 2024 | 2.87% |
| Jun 30, 2024 | 7.32% |
| Mar 31, 2024 | 18.18% |
| Dec 31, 2023 | 16.75% |
| Sep 30, 2023 | 20.72% |
| Jun 30, 2023 | 21.49% |
| Mar 31, 2023 | 21.70% |
| Dec 31, 2022 | 46.37% |
| Sep 30, 2022 | 7.32% |
| Jun 30, 2022 | -1.88% |
| Mar 31, 2022 | -1.79% |
| Dec 31, 2021 | -25.87% |
| Sep 30, 2021 | -1.91% |
| Jun 30, 2021 | 27.06% |
| Mar 31, 2021 | -2.87% |
| Dec 31, 2020 | -10.28% |
| Sep 30, 2020 | -27.64% |
| Jun 30, 2020 | -20.45% |
| Mar 31, 2020 | -7.24% |
| Dec 31, 2019 | -17.48% |
| Sep 30, 2019 | 2.19% |
| Jun 30, 2019 | -29.32% |
| Mar 31, 2019 | -20.91% |
| Dec 31, 2018 | 5.38% |
| Sep 30, 2018 | 3.52% |
| Jun 30, 2018 | 18.55% |
| Mar 31, 2018 | 22.32% |
| Dec 31, 2017 | 25.73% |
| Sep 30, 2017 | 30.38% |
| Jun 30, 2017 | 40.36% |
| Mar 31, 2017 | 28.91% |
| Dec 31, 2016 | 34.81% |
| Sep 30, 2016 | 31.45% |
| Jun 30, 2016 | 25.53% |
| Mar 31, 2016 | 30.91% |
| Dec 31, 2015 | 30.99% |
| Sep 30, 2015 | 46.23% |
| Jun 30, 2015 | 78.62% |
| Mar 31, 2015 | 108.43% |
| Dec 31, 2014 | 119.92% |
| Sep 30, 2014 | 107.98% |
| Jun 30, 2014 | 89.22% |
| Mar 31, 2014 | 69.25% |
| Dec 31, 2013 | 71.22% |
| Sep 30, 2013 | 102.62% |
| Jun 30, 2013 | 176.72% |
| Mar 31, 2013 | 211.82% |
| Dec 31, 2012 | 298.75% |
| Sep 30, 2012 | 269.59% |
| Jun 30, 2012 | 153.14% |
| Mar 31, 2012 | 255.16% |